Thrombogenic factors and recurrent coronary events

Arthur J. Moss, Robert E. Goldstein, Victor J. Marder, Charles E. Sparks, David Oakes, Henry Greenberg, Harvey J. Weiss, Wojciech Zareba, Mary W. Brown, Chang Seng Liang, Edgar Lichstein, William C. Little, John A. Gillespie, Lucy Van Voorhees, Ronald J. Krone, Monty M. Bodenheimer, Judith Hochman, Edward M. Dwyer, Rohit Arora, Frank I. MarcusLuc F.Miller Watelet, Robert B. Case

Research output: Contribution to journalArticle

248 Scopus citations

Abstract

Background - Thrombosis is a pivotal event in the pathogenesis of coronary disease. We hypothesized that the presence of blood factors that reflect enhanced thrombogenic activity would be associated with an increased risk of recurrent coronary events during long-term follow-up of patients who have recovered from myocardial infarction. Methods and Results - We prospectively enrolled 1045 patients 2 months after an index myocardial infarction. Baseline thrombogenic blood tests included 6 hemostatic variables (D-dimer, fibrinogen, factor VII, factor VIIa, von Willebrand factor, and plasminogen activator inhibitor-1), 7 lipid factors [cholesterol, triglycerides, HDL cholesterol, LDL cholesterol, lipoprotein(a), apolipoprotein (apo)A-I, and apoB], and insulin. Patients were followed up for an average of 26 months, with the primary end point being coronary death or nonfatal myocardial infarction, whichever occurred first. The hemostatic, lipid, and insulin parameters were dichotomized into their top and the lower 3 risk quartiles and evaluated for entry into a Cox survivorship model. High levels of D-dimer (hazard ratio, 2.43; 95% CI, 1.49, 3.97) and apoB (hazard ratio, 1.82; 95% CI, 1.10, 3.00) and low levels of apoA-I (hazard ratio, 1.84; 95% CI, 1.10, 3.08) were independently associated with recurrent coronary events in the Cox model after adjustment for 6 relevant clinical covariates. Conclusions - Our findings indicate that a procoagulant state, as reflected in elevated levels of D-dimer, and disordered lipid transport, as indicated by low apoA-1 and high apoB levels, contribute independently to recurrent coronary events in postinfarction patients.

Original languageEnglish
Pages (from-to)2517-2522
Number of pages6
JournalCirculation
Volume99
Issue number19
DOIs
StatePublished - May 18 1999

Keywords

  • Apolipoproteins
  • Coagulation
  • Coronary disease
  • Myocardial infarction
  • Thrombosis

Fingerprint Dive into the research topics of 'Thrombogenic factors and recurrent coronary events'. Together they form a unique fingerprint.

  • Cite this

    Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zareba, W., Brown, M. W., Liang, C. S., Lichstein, E., Little, W. C., Gillespie, J. A., Van Voorhees, L., Krone, R. J., Bodenheimer, M. M., Hochman, J., Dwyer, E. M., Arora, R., ... Case, R. B. (1999). Thrombogenic factors and recurrent coronary events. Circulation, 99(19), 2517-2522. https://doi.org/10.1161/01.CIR.99.19.2517